Completely agree. To see it being used in extremely complex scenarios with immunosuppressed patients battling severe infection and having great wound recovery outcomes is phenomenal. Throw a biological into that mess and you would have a soup for infection to thrive in. This is groundbreaking.
PNV Media Thread, page-897
-
- There are more pages in this discussion • 2,318 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
0.070(3.08%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.38 | $2.29 | $2.391M | 1.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 32377 | $2.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 36665 | 24 |
View Market Depth
| Last trade - 13.07pm 26/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |